רוקסו 150 ישראל - עברית - Ministry of Health

רוקסו 150

unipharm ltd, israel - roxithromycin - טבליה - roxithromycin 150 mg - roxithromycin - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

 טוברקס משחת עיניים ישראל - עברית - Ministry of Health

טוברקס משחת עיניים

novartis israel ltd - tobramycin - משחה לעין - tobramycin 0.3 % - tobramycin - tobramycin - antibiotic for the treatment of eye infections caused by bacteria sensitive to tobramycin.

טובי תמיסה לשאיפה ישראל - עברית - Ministry of Health

טובי תמיסה לשאיפה

dexcel ltd, israel - tobramycin - תמיסה לשאיפה - tobramycin 300 mg / 5 ml - tobramycin - tobramycin - for the management of cystic fibrosis patients with pseudomonas aeruginosa.

טוברקס 2 איקס ישראל - עברית - Ministry of Health

טוברקס 2 איקס

novartis israel ltd - tobramycin - טיפות עיניים - tobramycin 0.3 % - tobramycin - tobramycin - antibiotic for the treatment of superficial eye infections caused by bacteria sensitive to tobramycin.

טובי פודהלר 28 מג ישראל - עברית - Ministry of Health

טובי פודהלר 28 מג

dexcel ltd, israel - tobramycin - אבקה לשאיפה בקפסולות קשיחות - tobramycin 28 mg - tobramycin - tobramycin - suppressive therapy of chronic pulmonary infection due to pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.

ברמיטוב ישראל - עברית - Ministry of Health

ברמיטוב

kamada ltd, israel - tobramycin - תמיסה לשאיפה - tobramycin 300 mg / 4 ml - tobramycin - tobramycin - management of chronic pulmonary infection due to pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.

נאומיצין טבליות ישראל - עברית - Ministry of Health

נאומיצין טבליות

rekah pharmaceutical industry ltd, israel - neomycin sulfate - טבליה - neomycin sulfate 500 mg - neomycin - neomycin - diarrhea due to enteropathogenic escherichia coli. supression of intestinal bacteria prior to intestinal surgery or as an adjunct in hepatic coma.

מיטומיצין סי 10 מג ישראל - עברית - Ministry of Health

מיטומיצין סי 10 מג

dexcel ltd, israel - mitomycin c (crystalline) - אבקה להכנת תמיסה לזריקה - mitomycin c (crystalline) 10 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: - chronic lymphocytic leukemia, - chronic myelocytic leukemia, - gastric cancer, - colorectal cancer, - lung cancer, - pancreatic cancer, - liver cancer, - cervix cancer, - cancer of the endometrium, - breast cancer, - head and neck tumor, - bladder tumor.

מיטומיצין סי 2 מג ישראל - עברית - Ministry of Health

מיטומיצין סי 2 מג

dexcel ltd, israel - mitomycin c ( crystalline ) - אבקה להכנת תמיסה לזריקה - mitomycin c ( crystalline ) 2 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: chronic lymphocytic leukemia, chronic myelocytic leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervix cancer, cancer of the endometrium, breast cancer, head and neck tumor and bladder tumor.

זיילט ישראל - עברית - Ministry of Health

זיילט

abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect